Dmitriy Zamarin, MD PhD
Hematology-Oncology, Icahn School of Medicine at Mount Sinai
Planning Committee
Biography
Dmitriy Zamarin MD PhD is Professor of Oncology, Section Head of Gynecologic Medical Oncology, and co-director of Center of Excellence for Gynecologic Cancers at the Tisch Cancer Center at Icahn School of Medicine at Mount Sinai. Dr. Zamarin obtained his MD and PhD degrees from the Mount Sinai School of Medicine. He completed residency in Internal Medicine at the Mount Sinai Hospital and fellowship in Hematology/Oncology at the Memorial Sloan Kettering Cancer Center. He spent a decade as a faculty and Translational Research Director in Gynecologic Medical Oncology at the Memorial Sloan Kettering Cancer Center before transitioning to his current role in September of 2023. Dr. Zamarin has served as a principal investigator and a translational chair on multiple institutional and cooperative group clinical trials and serves as the translational research co-chair on the NRG Oncology Cervical Cancer committee. His clinical and laboratory research is focused on cancer cell-intrinsic mechanisms of immune recognition and resistance and development of novel therapeutics. Dr. Zamarin has received awards and funding from multiple organizations including Damon Runyon Foundation, Ovarian Cancer Research Alliance, Department of Defense, and the National Cancer Institute and is a member of the American Society for Clinical Investigation.
Financial Disclosure
Xencor, Memgen, BioInvent, Daiichi Sankyo, Gilead, Replimune, GSK, Eli Lilly
Consultant
Tikva Allocell, Calidi, OverT, Everest
Advisor
Volastra
Grant Or Contract
Tubulis
Grant Or Contract
Xencor
Grant Or Contract
OverT
Ownership Interest
Gilead
Consultant
GSK
Consultant
Calidi
Ownership Interest
Zymeworks
Grant Or Contract
Daiichi
Consultant
NextCure
Grant Or Contract
Eli Lilly
Consultant
Everest
Consultant